There is a direct implication of Abl1 as a therapeutic target to regulate GTPases in an effort to control ARDS and fibrosis as a result of disrupted endothelial barrier function and vascular leak in the lungs of ARDS patients (45, 82, 87). This evidence concerns the gene ABL1 and acute respiratory distress syndrome.